Table 1 Sensitivity analyses of foot-stomping metrics pre- vs post-neurofeedback. Wilcoxon signed-rank tests were conducted for (i) all participants (N=10), (ii) responders only (N=8), and after excluding non-responders individually (P01 or P09, N=9). Effect directions were consistent across analyses. All metrics remained significant when excluding P01, whereas exclusion of P09 led to a loss of significance for acceleration magnitude (p = 0.074). The reduction in significance in smaller subsets reflects decreased statistical power rather than reversal of the observed effects.

From: Lower limb motor effects of DBS neurofeedback in Parkinson’s disease assessed through IMU-based UPDRS movement quality metrics

Metric

All (N=10)

Responders (N=8)

Excl. P01 (N=9)

Excl. P09 (N=9)

Steps per second

+5.71%; W = 3.0, p = 0.010**

W = 3.0, p = 0.039*

W = 4.0, p = 0.020*

W = 4.0, p = 0.020*

Mean peak velocity

+36.07%; W = 0.0, p = 0.002**

W = 0.0, p = 0.008**

W = 1.0, p = 0.004**

W = 1.0, p = 0.004**

Step interval

–4.54%; W = 5.0, p = 0.020*

W = 5.0, p = 0.078

W = 7.0, p = 0.039*

W = 7.0, p = 0.039*

Acceleration magnitude

+14.51%; W = 7.0, p = 0.037*

W = 5.0, p = 0.078

W = 8.0, p = 0.039*

W = 10.0, p = 0.074